GEC-067t

N/A

Report date: 2023/12/28 11:19:24

Base Information

Drug NameGEC-067t
Drug Alias NameGEC-067t
ClassificationOther
Mechanisms of ActionIsocitrate dehydrogenase [NADP] cytoplasmic inhibitors
TargetsIsocitrate dehydrogenase [NADP] cytoplasmic
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenEros Biopharma Hangzhou Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenEros Biopharma Hangzhou Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A